Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Adam Cribbs and Luke Jostins

Associate Professor Adam Cribbs leads a computational biology team with a broad interest in systems biology, immunology and epigenetics. On being named Associate Professor, he said “It’s a great privilege to have been awarded Associate Professor within NDORMS. I owe this recognition because of the hard work and dedication of my DPhil students, postdocs, collaborators and mentors that have allowed my research to flourish.”

Associate Professor Luke Jostins focuses his research on identifying genetic associations with diagnosis or disease prevention in inflammatory bowel disease, and developing statistical techniques to understand the function of genetic risk variants. On being awarded the title Associate Professor, he said “I am delighted and honoured to receive this recognition from the university. I am very grateful to all my group members and collaborators, and particularly to my talented graduate students Benjamin Frot, Alan Yang and Chris Eijsbouts, who worked with me to produce the research that this award recognises.”

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).